Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has announcements × Recurrence × Clear all

Phase

Status

Sponsor Class

INDUSTRY 18 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Ototoxicity 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, B-Cell 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Hepatoblastoma 1 Graft vs Host Disease 1 Esophageal Squamous Cell Carcinoma 1 Burkitt Lymphoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed

289 enrolled 32 charts 1 FDA

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡